Informed Girl
← Back to the research library

Playbook

What should I actually do about lupus?

Lupus is an autoimmune disease that can affect almost any part of the body, and it is roughly nine times more common in women. It looks different in everyone, which is why it is often missed. This walks you through recognizing it, the tests that pin it down, and what good, modern treatment actually looks like.

Lupus · reviewed July 2026 · 14 cited papers

See a clinician promptly if

  • !Foamy urine, leg swelling, or newly high blood pressure. Can signal lupus nephritis (kidney inflammation), which needs prompt treatment to prevent lasting kidney damage.
  • !Chest pain, severe headache, confusion, seizures, or new weakness. Lupus can affect the heart lining, lungs, and nervous system, and these need urgent assessment.
  • !Fever with feeling very unwell while on immune-suppressing drugs. Lupus treatments raise infection risk, and serious infection can look like a flare, so it needs prompt evaluation.

Step 1

Could this be lupus?

Lupus has many faces, which is part of why it takes so long to diagnose. Here are the common ways it shows up and the features that push toward a lupus work-up rather than something else.

Step 2

What to get checked

Lupus is diagnosed from a pattern of clinical features plus specific blood tests. These are the ones that matter, and monitoring continues after diagnosis.

ANA, then specific antibodies (anti-dsDNA, anti-Sm) and complement

A positive ANA is the entry point; more specific antibodies and low complement levels support the diagnosis and help track activity.

Urine test for protein and blood, plus kidney function

Screens for lupus nephritis, which can be silent, and is repeated over time.

Full blood count

Lupus can lower white cells, platelets, or red cells, which is part of the picture and needs monitoring.

Antiphospholipid antibodies (especially before pregnancy)

These raise clotting and pregnancy risks, so they guide both general care and pregnancy planning.

Step 3

What good treatment looks like

The aim of modern lupus care is remission or low disease activity on the least medication needed, especially the least steroid. This is roughly how the pieces fit together.

Start hereStrong evidence

Hydroxychloroquine for nearly everyone

The foundation of lupus treatment. It reduces flares and organ damage and improves survival, and it is recommended for essentially all patients. Dosed by weight (at or below 5 mg/kg) with periodic retinal screening, it is generally very safe.

TimelineWorks gradually over weeks to months and is taken long term.

How to get itPrescription.

CautionsNeeds a baseline eye exam and periodic retinal screening, especially after five years.

Start hereModerate evidence

Minimize steroids

Short steroid courses calm flares quickly, but higher ongoing doses cause irreversible organ damage over time. Good care uses the lowest effective dose and tapers off wherever possible.

CautionsDo not stop steroids abruptly; tapering is done with your doctor.

Add on / step upStrong evidence

Steroid-sparing immunosuppressants and biologics

Drugs like mycophenolate (especially for kidney disease) and biologics such as belimumab or anifrolumab control active disease and let you lower steroids. Voclosporin is an added option for lupus nephritis.

TimelineMonths to judge; used for persistent or organ-threatening disease.

How to get itPrescription, specialist-managed.

CautionsRaise infection risk; need screening and monitoring. Several are unsafe in pregnancy.

Add on / step upModerate evidence

Sun protection and vitamin D

Ultraviolet light triggers flares, so daily sun protection is genuine treatment. Because sun avoidance makes vitamin D deficiency common, checking and correcting it is sensible and may modestly help inflammation.

How to get itOver the counter.

Add on / step upModerate evidence

Active cardiovascular risk management

Lupus accelerates artery disease beyond usual risk factors, so blood pressure, cholesterol, and smoking deserve active attention even in younger women, alongside controlling disease activity.

Set your expectations

  • Lupus is managed, not cured. The realistic goal is long stretches of low activity with minimal steroids.
  • Hydroxychloroquine is worth staying on even when you feel well, because it prevents flares and damage.
  • Flares can be triggered by sun, infection, and sometimes stress, and a plan is about reducing their frequency and impact.
  • If you may want to become pregnant, plan it during remission and review medications well in advance.

Step 4

Take this to your doctor

I have symptoms across several body systems and want to be properly assessed for lupus, and if I have it, to build a plan that keeps my steroids as low as possible.

Questions to ask

  • Which of my antibodies are positive, and which organs are involved right now?
  • Am I on hydroxychloroquine, and is my dose within the eye-safety limit?
  • What is our plan to taper steroids and use steroid-sparing drugs?
  • How are my kidneys and cardiovascular risk being monitored?

What to bring

  • A record of your symptoms, rashes, and flares over time, including any sun triggers
  • Your antibody and kidney test results if you have them
  • Your reproductive plans, since they shape medication choices

When to push. Ask for prompt rheumatology input for any kidney, heart, lung, or neurological symptoms, and for pre-pregnancy counseling before trying to conceive.

Step 5

Where the science is going

Interferon-targeting and B-cell biologics

Newer biologics such as anifrolumab (which blocks the interferon pathway) and belimumab have expanded options for active lupus and help reduce steroids, with more targeted therapies in development.

All sources

Every claim above links to peer-reviewed research. Full list below.

  1. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (2019). Arthritis & Rheumatology. doi.org/10.1002/art.40930
  2. Systemic lupus erythematosus (2024). The Lancet. doi.org/10.1016/S0140-6736(24)00398-2
  3. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies (2017). Rheumatology (Oxford). doi.org/10.1093/rheumatology/kex260
  4. Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis (2020). Mayo Clinic Proceedings. doi.org/10.1016/j.mayocp.2019.09.012
  5. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision) (2016). Ophthalmology. doi.org/10.1016/j.ophtha.2016.01.058
  6. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update (2024). Annals of the Rheumatic Diseases. doi.org/10.1136/ard-2023-224762
  7. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (2021). The Lancet. doi.org/10.1016/S0140-6736(21)00578-X
  8. Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study (2015). Annals of Internal Medicine. doi.org/10.7326/M14-2235
  9. Trial of Anifrolumab in Active Systemic Lupus Erythematosus (2020). New England Journal of Medicine. doi.org/10.1056/NEJMoa1912196
  10. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial (2011). The Lancet. doi.org/10.1016/S0140-6736(10)61354-2
  11. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus (2003). New England Journal of Medicine. doi.org/10.1056/NEJMoa035471
  12. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus (2014). Rheumatology (Oxford). doi.org/10.1093/rheumatology/keu148
  13. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial (2013). The Journal of Rheumatology. doi.org/10.3899/jrheum.111594
  14. Exercise and physical activity in systemic lupus erythematosus: A systematic review with meta-analyses (2017). Seminars in Arthritis and Rheumatism. doi.org/10.1016/j.semarthrit.2017.04.003

This playbook is educational and is not medical advice. Hair loss has many causes and individual treatment decisions belong with a clinician who can examine you.

The Weekly Briefing

Stay informed

Every paper is individually reviewed and scored for study design, blinding, and funding independence. Educational content, not medical advice.

Subscribe for updates about the latest research. No spam.